Accelsiors CRO

𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝘁𝗼 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲 𝘄𝗵𝗼 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗲𝗱 𝗶𝗻 𝗼𝘂𝗿 𝗿𝗲𝗰𝗲𝗻𝘁 𝗽𝗼𝗹𝗹! We asked, “What’s the toughest hurdle in recruiting for Endocrinology Clinical Trials?” Here’s what you told us: 1. 𝗛𝗶𝗴𝗵 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗙𝗮𝗶𝗹𝘂𝗿𝗲 𝗥𝗮𝘁𝗲𝘀: 56% 2. 𝗗𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁 𝗖𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀: 25% 3. 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝗞𝗲𝘆-𝗦𝗶𝘁𝗲 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀: 6% 4. 𝗟𝗼𝘄 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗔𝗺𝗼𝗻𝗴 𝗣𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀: 13% The results highlight that high screening failure rates are a substantial barrier, impacting the ability to recruit suitable participants and potentially delaying the development of treatments for endocrine disorders. 𝗪𝗵𝘆 𝗱𝗼 𝘆𝗼𝘂 𝘁𝗵𝗶𝗻𝗸 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗳𝗮𝗶𝗹𝘂𝗿𝗲 𝗶𝘀 𝘀𝗼 𝗵𝗶𝗴𝗵 𝗶𝗻 𝘁𝗵𝗶𝘀 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗮𝗿𝗲𝗮? Learn more about effective approaches to tackling these challenges by visiting our page: https://lnkd.in/dshbNSmw

We are excited to share our insights from the #ALIMS Symposium 2.0 at Kopaonik. Our VP of Regulatory Affairs, Vlada Injac, and our regulatory group gathered among various agencies from around the world and engaged with industry experts on key clinical trial regulation topics.   The agenda featured sessions focused on 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹 𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗲𝘀 𝗳𝗼𝗿 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲𝘀, essential 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀, and the transformative role of 𝗮𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗶𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵.   During an interactive panel discussion, we collaborated with directors from medical agencies across the region, tackling pressing issues like drug shortages and the importance of cross-agency cooperation for enhancing regulatory efficiency. We are particularly excited about ALIMS's 𝗻𝗲𝘄 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗦𝘆𝘀𝘁𝗲𝗺 (𝗥𝗜𝗠𝗦), which will revolutionize data handling and transparency in clinical trial approvals.   👉 Let’s keep the conversation going! How is your organization adapting to the evolving landscape of clinical research? Share your thoughts in the comments!

Recruiting for endocrinology trials—especially for conditions like Growth Hormone Deficiency (GHD) and Acromegaly— is becoming increasingly complex. But with every challenge comes an opportunity for innovation.    Learn more about our approach to overcome some of these challenges >> https://lnkd.in/dcEkjrjT       👇 𝗩𝗼𝘁𝗲 & 𝘀𝗵𝗮𝗿𝗲 𝘆𝗼𝘂𝗿 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 👇    What’s been your biggest recruitment challenge lately? Drop your thoughts in the comments.  

𝗙𝗗𝗔 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀 𝗨𝗽𝗱𝗮𝘁𝗲: 𝗗𝗖𝗧𝘀 𝘄𝗶𝘁𝗵 𝗿𝗲𝗺𝗼𝘁𝗲 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻!   The FDA issued new guidelines on decentralized clinical trials (DCTs), which allow remote participation. This shift is expected to reduce barriers to patient enrollment and improve diversity in clinical trials, addressing long-standing challenges in clinical research.   For access to the full guidelines on the FDA’s website >> https://lnkd.in/exDQdykh   And shall you need assistance navigating these new guidelines, or further regulatory complexities, have a look at our Regulatory Strategy Consulting page >> https://lnkd.in/dAPn3UiQ   We are always here to answer any questions. Feel free to get in touch with us at bdglobal@accelsiors.com

𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗟𝗲𝗮𝗱 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀?    The global neurology clinical trials market is projected to grow significantly, with a value of USD 5.89 billion in 2024 and an estimated USD 9.64 billion by 2033.  𝗞𝗲𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: 𝗨.𝗦. 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽: The U.S. neurology clinical trials market led North America, with a size of USD 2.01 billion in 2023. By 2033, it's projected to reach USD 3.53 billion, growing at a CAGR of 5.79%. 𝗣𝗵𝗮𝘀𝗲 𝗜𝗜 𝗗𝗼𝗺𝗶𝗻𝗮𝗻𝗰𝗲: Phase II trials generated over 47% of total revenue in 2023. This phase is crucial for evaluating the safety and efficacy of emerging treatments. 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗚𝗿𝗼𝘄𝘁𝗵: The increasing prevalence of conditions like epilepsy, and Parkinson's is fueling the demand for advanced clinical trials. The epilepsy segment captured more than 23% of revenue in 2023. Accelerate your research and drive innovative solutions with our clinical trial services. Reach out to 𝗯𝗱𝗴𝗹𝗼𝗯𝗮𝗹@𝗮𝗰𝗰𝗲𝗹𝘀𝗶𝗼𝗿𝘀.𝗰𝗼𝗺 to explore how we can assist you with your neurology trials in this ever-evolving market and help you achieve success.

𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗔𝗰𝗰𝗲𝗹𝘀𝗶𝗼𝗿𝘀 𝗦𝘁𝘂𝗱𝗲𝗻𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗛𝗨𝗕! We’re excited to announce our new platform, designed to transform young talents into innovative leaders and support them in their academic and professional journey in clinical research. Whether you’re an aspiring student or a recent graduate, our platform offers resources, insights, and opportunities to help you grow and thrive. 𝗪𝗵𝗮𝘁 𝘄𝗶𝗹𝗹 𝘆𝗼𝘂 𝗳𝗶𝗻𝗱? • Career development resources • Networking opportunities • The latest industry news Check it out now and take the first step towards your future >> https://lnkd.in/ghcKVif3

What an inspiring and productive weekend!  The "Anxiety – An Obstacle to Success" congress, organized by Kragujevac Pharmacy Student's Association, brought together future healthcare professionals for insightful discussions, workshops, and real-world advice.  𝗞𝗲𝘆 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: 🧠 The theme of the congress addressed a significant challenge faced by students, providing insights into overcoming professional and academic hurdles. 🤝 The event facilitated valuable networking opportunities among students, academics, and professionals, fostering connections that could lead to future collaborations. 🏢 The lectures, panel discussions, and workshops, allowed distinguished colleagues to share their expertise and offered students comprehensive insights about the industry and practical advice for their transition to professional career. A big thank you to all the speakers, attendees, and organizers for making this event such a success. We’re proud to have been part of it and can’t wait for the next opportunity to collaborate with #KgPSA. Learn more about our team’s experience! >>  https://lnkd.in/dMxVe4nk  #clinicalresearch #clinicaltrials #cro #KgPSA2024

𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗘𝘃𝗲𝗻𝘁 𝗦𝘁𝗮𝗿𝘁𝘀 𝗧𝗼𝗺𝗼𝗿𝗿𝗼𝘄! 🎓 The 3rd Mini-Congress, organized by the KgPSA - Kragujevac Pharmacy Student's Association, is just a day away! This year’s theme, "Anxiety – An Obstacle to Success," promises engaging discussions, workshops, and valuable insights. Key highlights: • “𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡”: A workshop will bring together medical and pharmacy students collaborating to solve clinical cases.  • “𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐂𝐨𝐮𝐧𝐬𝐞𝐥𝐢𝐧𝐠 𝐩𝐫𝐨𝐣𝐞𝐜𝐭”: In this workshop, pharmacy students will demonstrate their knowledge and skills in working with patients. • "𝐖𝐡𝐚𝐭 𝐀𝐟𝐭𝐞𝐫 𝐂𝐨𝐥𝐥𝐞𝐠𝐞?": A panel discussion featuring four former pharmacy students who share their journey since graduation. Among them, our Business Opportunity Researcher, Ivana Bogdanović. 📅 Opening at October 5, 11:30 AM 📍 Location: Amphitheater, Faculty of Medical Sciences, Kragujevac We’re proud to support this event and look forward to hearing inspiring stories. Don’t miss the opportunity to gain insights and connect with future healthcare professionals! Check out the full agenda and event details here >> https://lnkd.in/dvFPM-SN #clinicalresearch #KgPSA2024

𝗛𝗲𝗿𝗲 𝗮𝗿𝗲 𝗹𝗮𝘀𝘁 𝗺𝗼𝗻𝘁𝗵'𝘀 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝘀 𝗶𝗻 𝗻𝗲𝘂𝗿𝗼-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵! Over the past 20 years, we’ve seen incredible progress in understanding the causes of nervous system disorders, bringing us closer to more effective and personalized treatments that have the potential to change lives. Whether it’s uncovering new insights into epilepsy, or Parkinson’s disease, we’re dedicated to turning these discoveries into actionable solutions for clinical research and patient care. Want to stay updated or learn how breakthroughs could shape future therapies? Follow us for more insights or reach out to discuss how we can support your clinical research >> https://lnkd.in/daCFgscE   #Neurology #Epilepsy #Parkinsons #ClinicalResearch #Innovation

𝑰𝒕 𝒊𝒔 𝒉𝒆𝒓𝒆. 𝑰𝒕 𝒊𝒔 𝒏𝒆𝒘. 𝑰𝒕 𝒊𝒔 𝒆𝒗𝒐𝒍𝒖𝒕𝒊𝒐𝒏.   We are proud to unveil our refreshed Accelsiors logo, marking a refined update in our company's brand evolution, reflecting a fresh, modern take on our brand identity.    Our new visual identity reflects who we are today: • Modern and bold • Embodying our dynamic approach • Conveying our mission for growth and innovation • Staying true to our core values   This brand refresh reflects the collective dedication and professionalism demonstrated by each member of our team. We are grateful for your continued support in our journey, and invite you to share your thoughts on our new look as we embrace this next chapter. #accelsiors #cro #clinicalresearch #innovation